Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents Diego García-Compeán; Ramesh Kumar; Ángel Noe del Cueto-Aguilera; Héctor Jesús Maldonado-Garza; Jesús Zacarías Villarreal-Pérez;

The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;

What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;